Phase II study of transesophageal bronchoscopic ultrasound-guided fine needle aspiration (TEBUS-FNA) using an EBUS bronchoscope in the diagnosis of sarcoidosis

Phase II study of transesophageal bronchoscopic ultrasound-guided fine needle aspiration (TEBUS-FNA) using an EBUS bronchoscope in the diagnosis of sarcoidosis - TEBUS-FNA in the diagnosis of sarcoidosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002883

Enrollment

Registered

2009-12-12

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Interventions

TEBUS-FNA in the diagnosis of sarcoidosis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with suspected stage I/II sarcoidosis based on clinicoradiological pictures who have hilar-mediastinal nodes 10 mm or greater in short-axis diameter on CT 2. 18 years or older 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Serious concomitant medical illness 2. SPO2<90% with supplemental oxygen 3. Obvious bleeding tendency 4. Pregnancy 5. Other clinical difficulties in this study

Design outcomes

Primary

Measure	Time frame
1. Sensitivity of pathological diagnosis of sarcoidosis	—

Secondary

Measure	Time frame
1. Time of procedure 2. Sensitivity: according to lymph node location, cytology or histology, stage I or II 3. Frequency of adverse effects 4. Feasibility	—

Countries

Japan

Contacts

Public ContactMasahide Oki

Nagoya Medical Center Department of Respiratory Medicine

masahideo@aol.com052-951-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026